Storage and handling
Other information read all warnings and directions before use store at 20-25ºC (68-77ºF)
Other information read all warnings and directions before use store at 20-25ºC (68-77ºF)
Active ingredient (in each caplet)
Ibuprofen 200 mg (NSAID)*
*nonsteroidal anti-inflammatory drug
Purposes
Pain reliever/fever reducer
Uses
temporarily relieves minor aches and pains due to:
temporarily reduces fever
Warnings
Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:
Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed
Do not use
Ask a doctor before use if
Ask a doctor or pharmacist before use if you are
When using this product
Stop use and ask a doctor if
you experience any of the following signs of stomach bleeding:
you have symptoms of heart problems or stroke:
pain gets worse or lasts more than 10 days
fever gets worse or lasts more than 3 days
redness or swelling is present in the painful area
any new symptoms appear
If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
Other information
Directions
do not take more than directed
the smallest effective dose should be used
| adults and children 12 years and older |
|
| children under 12 years |
|
Inactive ingredients colloidal silicon dioxide, croscarmellose sodium, FD&C yellow #6 aluminum lake, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, pregelatinized starch, talc, titanium dioxide
Questions or comments? Call 1-877-290-4008
| Class | Version | Type | Effective |
|---|---|---|---|
| IBUPROFEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| 16cde546-8deb-4df2-a072-dab5566ede95 | Product name | 1 | 20231003 |
| f6d1b8d7-3bd1-4248-eddd-b60565c88015 | Product name | 4 | 20230808 |
| 874f4e63-49d2-5150-5d77-052172814ebd | Product name | 6 | 20230105 |
| 557673c2-8256-b351-e863-4ec71a5a64b0 | Product name | 2 | 20160714 |
| dbc9a339-6215-4e94-9546-57a3b34902ce | Product name | 1 | 20160517 |
| 61c18d4e-b552-5478-8fc0-df38b93e3100 | Product name | 1 | 20140508 |
| 7b2938c9-7eb7-e312-ae90-f54f4240361e | Product name | 1 | 20140508 |
| 997601aa-bb5f-6971-6b90-a21132c12c7b | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11673-993-01 | IBUPROFEN | 100 in 1 BOTTLE | TABLET, COATED | 100 | 5 | |
| 11673-993-26 | IBUPROFEN | 225 in 1 BOTTLE | TABLET, COATED | 225 | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 11673-993 | 11673-993-01, 11673-993-26 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| FD&C YELLOW NO. 6 | H77VEI93A8 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| POLYVINYL ALCOHOL, UNSPECIFIED | 532B59J990 | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| TALC | 7SEV7J4R1U | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| IBUPROFEN | WK2XYI10QM | ACTIB |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091237-001 | IBUPROFEN | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| IBUPROFEN | IBUPROFEN | TARGET CORPORATION | 8e872c8d-28e2-cd49-e053-2995a90a469f | 2024-01-03 | Warnings | 11673-993-26 11673-993-01 11673-993 11673099326 11673099301 0e07c84c-691d-97b3-e063-6394a90aa81d 8e872c8d-28e2-cd49-e053-2995a90a469f |
Adverse event summaries are temporarily unavailable. Other product information remains available.